Q3 2011 Earnings Call
October 26, 2011 9:00 am ET
Thomas E. Werner - Chief Financial Officer and Senior Vice President of Finance
Sumant Ramachandra - Chief Scientific Officer and Senior Vice President of Research & Development & Medical Affairs
Karen King - Vice President Investor Relations
Michael Michael Ball - Chief Executive Officer, Director and Member of Science, Technology & Quality Committee
Gregory Hertz - Citigroup Inc, Research Division
Robert M. Goldman - CL King & Associates, Inc.
Gregory B. Gilbert - BofA Merrill Lynch, Research Division
Frederick A. Wise - Leerink Swann LLC, Research Division
Jessica Fye - JP Morgan Chase & Co, Research Division
Jayson T. Bedford - Raymond James & Associates, Inc., Research Division
Matthew Taylor - Barclays Capital, Research Division
David H. Roman - Goldman Sachs Group Inc., Research Division
Shibani Malhotra - RBC Capital Markets, LLC, Research Division
Marshall Urist - Morgan Stanley, Research Division
David G. Buck - Buckingham Research Group, Inc.
Louise A. Chen - Collins Stewart LLC, Research Division
Welcome to Hospira's Third Quarter 2011 Conference Call. [Operator Instructions] I will now turn the call over to Karen King, Vice President of Investor Relations. Karen, you may now begin your conference.
Thank you. Good morning, everyone, and welcome to our conference call and webcast regarding Hospira's financial results for the third quarter of 2011. Participating in today's call are Mike Ball, Chief Executive Officer of Hospira; Tom Werner, Senior Vice President of Finance and Chief Financial Officer; Sumant Ramachandra, Senior Vice President and Chief Scientific Officer, will also be joining us for Q&A.